Principal Investigator - Prof Dame Lesley Fallowfield
Principal Investigator - Prof Val Jenkins
Researcher - Dr Helena Harder
Researcher - Dr Valerie Shilling
Researcher - Niomie Wogan
Data Manager - Dr Ruth Habibi
Data Manager - Shirley May
Funder: BCRF
There is interest worldwide about using a drug called a PARP inhibitor (PARPi) in people with BRCA 1 or BRCA 2 gene changes. These drugs already work in patients with cancer who have gene changes. We hope that PARP inhibitors given to those with gene changes who do not have cancer will stop a cancer developing. Before doctors can design a chemoprevention trial using this drug, we need to find out the preferences and acceptability of such a study. Initial insights gained from members of the public - in this instance women - will help with trial design and the sort of information required.
This pilot aims to explore the views of women who do not have breast cancer about a potential new treatment designed to reduce cancer risk in women with specific gene changes.
Recruitment aim: 30 Current Stage:
Recruiting
EMAIL: adminshore-c@sussex.ac.uk
PHONE: 01273 873019
BlueSky: https://bsky.app/profile/shore-c.bsky.social
LOCATION: MAP